Results 1 to 5 of 5
Most popular |Most recent

Bristol-Myers Squibb Canada Co. and Merck Sharp & Dohme Corp. v Mylan Pharmaceuticals, 2011 FC 919, July 25, 2011 - efavirenz

Canada - August 22 2011 As a part of a Patented Medicines (Notice of Compliance) Regulations proceeding, the applicants had filed a motion for the production of certain further documents by the respondent, namely documents that would go to what crystalline forms were used in the making of the generic product, including under s. 6(7) of the Regulations.

U.S. government now anti-gene patents?

USA - November 24 2010 The Justice Department of the United States government recently filed an amicus brief in an appeal of a U.S. Federal Court decision regarding the patentability of naturally-occurring DNA sequences, taking the position that that these are not patentable as “part of nature.”

New study argues for economic efficacy of national "pharmacare" program

Canada - September 21 2010 A study released on September 13, 2010 by the Canadian Centre for Policy Alternatives claims that billions of dollars could be saved if the provincial governments could agree on a joint, national plan for purchasing both brand-name and generic pharmaceuticals.

Provincial funding for IVF

Canada - August 26 2010 Quebec recently became the first the first jurisdiction in North America to offer a government-funded program for in vitro fertilization (IVF).

EU decides functionality critical for infringement of gene patents

European Union - July 16 2010 The Court of Justice of the European Union ruled on July 6, 2010 that soy meal imported from Argentina produced from Roundup Ready® soybeans does not infringe a Monsanto gene patent since the gene in question in the soy meal cannot perform its function, as is required by Article 9 of Directive 98/44/EC of the European Parliament and of the Council of 6 July 1998 on the legal protection of biotechnological inventions.